UBS Adjusts Price Target on CareMax to $2.20 From $6.40, Maintains Neutral Rating

11:51 AM EDT, 07/15/2024 (MT Newswires) -- UBS Adjusts Price Target on CareMax to $2.20 From $6.40, Maintains Neutral RatingPrice: 2.06, Change: -0.09, Percent Change: -4.19

MT NewswiresJul 15 11:51 ET

UBS Maintains CareMax(CMAX.US) With Hold Rating, Cuts Target Price to $2.2

UBS analyst A.J. Rice maintains $CareMax(CMAX.US)$ with a hold rating, and adjusts the target price from $6.4 to $2.2.According to TipRanks data, the analyst has a success rate of 61.0% and a total

Moomoo NewsJul 14 06:31 ET · Ratings

Express News | CareMax-Eighth Amendment Amended Credit Agreement for New Incremental Delayed Draw Term Loan Facility in Principal Amount of $16.0 Mln

ReutersJul 11 06:59 ET

Express News | CareMax Inc -Eighth Amendment Amended Credit Agreement to, Among Other Things, Provide for New $4.0 Mln Term Loan

ReutersJul 11 06:57 ET

Express News | CareMax Inc -on July 10, Entered Into Limited Waiver & Eighth Amendment to That Certain Credit Agreement, Dated as of May 10, 2022

ReutersJul 11 06:57 ET

Express News | CareMax Inc - Extended Seventh Amendment Amended Credit Agreement to Extend Waiver of Certain Events of Default Under Credit Agreement

ReutersJul 9 06:58 ET